Supplement powder and dumbbell representing creatine science
| | |

Creatine for Longevity: What 2026 Research Reveals About Muscle, Brain, and Healthy Aging

For decades creatine was framed as a supplement for lifters. In 2026, new research on cognition, mood, bone density, and sarcopenia is repositioning creatine as a foundational tool for healthy…

Luminous mitochondria undergoing quality control as NAD+ and MOTS-c signals support cellular aging
| |

The Mitochondrial Decade: Urolithin A, NAD+, MOTS-c, and the 2026 Science of Cellular Aging

In 2026, mitochondria have moved from a footnote in biology textbooks to the central organelle of aging research. From urolithin A’s mitophagy revolution to new NAD+ trials, MOTS-c, and the…

VO2 max testing visual showing oxygen flow from lungs and heart to mitochondria for longevity fitness
| | |

VO2 Max and the Longevity Prescription: What 2026 Research Reveals About Cardiorespiratory Fitness

In 2026, cardiorespiratory fitness is the most validated longevity marker in medicine. From Cleveland Clinic mortality data to Ulrik Wisløff’s 4 by 4 intervals and Iñigo San Millán’s zone 2…

Healthcare Discovery klotho protein longevity cognitive aging 2026 showing kidney-brain signaling and memory resilience
| | |

The Klotho Protein: How a Single Longevity Hormone Is Reshaping Brain Aging Research in 2026

Discovered almost by accident in 1997 and named after the Greek fate that spins the thread of life, klotho is the longevity hormone that may connect kidney biology, cognitive aging,…

Healthcare Discovery centenarian gut microbiome longevity 2026 showing bile acids Akkermansia and microbial diversity
| | |

The Centenarian Gut: How Bile Acids, Akkermansia, and Microbial Diversity Are Rewriting Longevity Science in 2026

New 2026 research is reshaping longevity medicine through the gut. From Kenya Honda’s discovery of isoalloLCA in Japanese centenarians, to Patrice Cani’s Akkermansia muciniphila trials at UCLouvain, to the ARMOR…

Healthcare Discovery longevity science reckoning coordination paradigm showing aging as interconnected biological systems
| |

Longevity Science Is Having a Reckoning: Why the Next Breakthrough May Not Be a Drug

Scientists at the 2nd World Congress on Targeting Longevity in Berlin delivered an uncomfortable verdict in April 2026: despite decades of discoveries, longevity science has stalled on clinical translation. The…

Skeletal muscle releasing myokine signals toward the brain during strength training for longevity | Healthcare Discovery
| | |

Myokines and the Muscle Brain Axis: What 2026 Research Reveals About Strength Training and Longevity

New 2026 research on myokines, the signaling proteins released by contracting muscle, shows why strength training is a cognitive intervention. Here is what the science reveals about irisin, cathepsin B,…

Healthcare Discovery cardiac amyloidosis ATTR therapy revolution 2026 showing transthyretin protein misfolding and heart failure treatment
| | |

The Cardiac Amyloidosis Revolution: How ATTR Therapies Are Rewriting Heart Failure Treatment in 2026

For decades, cardiac amyloidosis was a diagnosis cardiologists whispered and patients rarely heard. In 2026, tafamidis, acoramidis, RNA silencers, and a CRISPR gene editing therapy are transforming ATTR care and…

Deep slow-wave sleep driving glymphatic brain cleanup as cerebrospinal fluid clears amyloid and tau
| | |

Deep Sleep and the Brain’s Glymphatic System: What 2026 Sleep Science Reveals About Your Nightly Cleanup

New glymphatic research reveals that deep slow wave sleep drives the brain’s nightly clearance of amyloid and tau, with 2026 data linking sleep architecture to long term dementia risk and…

Healthcare Discovery lipoprotein(a) treatment breakthrough 2026 showing inherited Lp(a) cardiovascular risk and RNA therapies
| | |

The Lp(a) Revolution: How 2026 Became the Year Cardiology Finally Learned to Treat Its Oldest Blind Spot

Phase 3 trials of pelacarsen, olpasiran, lepodisiran, and the first oral Lp(a) drug muvalaplin are ending cardiology’s sixty year blind spot on lipoprotein(a), a genetically determined particle that silently elevates…